Sparked provides a non-invasive, handheld device that uses saliva samples for rapid cardiovascular disease risk screening. Its proprietary technology analyzes saliva biomarkers to deliver actionable risk insights within minutes, enabling earlier detection and intervention.
Funding
Funding not disclosed
Founders
Product
Problem
Current methods for cardiovascular disease (CVD) risk assessment often involve complex laboratory analyses or invasive procedures, limiting their accessibility and speed for early detection. This delay in obtaining actionable health data hinders proactive management of CVD, a leading global health concern.
Solution
Sparked offers a non-invasive, handheld diagnostic device that utilizes saliva samples for rapid cardiovascular disease risk screening. The proprietary technology analyzes biomarkers present in saliva to provide actionable risk insights within minutes. This approach democratizes access to essential health diagnostics, enabling individuals and healthcare providers to identify potential risks earlier and implement timely interventions. The device is designed for ease of use, facilitating frequent and convenient health monitoring.
Target Audience
The primary target audience includes individuals seeking proactive health monitoring and healthcare providers, such as primary care physicians and clinics, looking for efficient CVD risk screening tools.
Features
- Handheld, non-invasive diagnostic device for saliva sample analysis.
- Rapid biomarker detection for cardiovascular disease risk assessment.
- Results delivered in minutes, facilitating immediate clinical decision-making.
- Portable form factor for accessible point-of-care or at-home use.
- Proprietary analytical technology for biomarker quantification.